Klein R, Lee KE, Gangnon RE, Klein BEK. Incidence of visual impairment over a 20-year period: The beaver dam eye study. Ophthalmology. 2013;120:1210–9.

Article  PubMed  Google Scholar 

Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392:1147–59.

Article  PubMed  Google Scholar 

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for Neovascular Age-Related Macular Degeneration. n engl j med. 2006;14:355.

Google Scholar 

Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, et al. Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. In: Ophthalmology. Elsevier Inc., 2016, pp 1751-61.

Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537–48.

Article  PubMed  Google Scholar 

Segal O, Barayev E, Nemet AY, Geffen N, Vainer I, Mimouni M. PROGNOSTIC VALUE of HYPERREFLECTIVE FOCI in NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED with BEVACIZUMAB. Retina. 2016;36:2175–82.

Article  CAS  PubMed  Google Scholar 

Pokroy R, Mimouni M, Barayev E, Segev F, Geffen N, Nemet AY, et al. Prognostic Value of Subretinal Hyperreflective Material in Neovascular Age-Related Macular Degeneration Treated With Bevacizumab. Retina. 2018;38:1485–91.

Article  CAS  PubMed  Google Scholar 

Segal O, Barayev E, Nemet AY, Mimouni M. Predicting Response Of Exudative Age-Related Macular Degeneration To Bevacizumab Based On Spectralis Optical Coherence Tomography. Retina. 2016;36:259–63.

Article  CAS  PubMed  Google Scholar 

Rabina G, Ayalon A, Mimouni M, Stanescu N, Moisseiev E, Nemet AY, et al. Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization. Ophthalmologica 2022;245:342–9.

Sacconi R, Forte P, Tombolini B, Grosso D, Fantaguzzi F, Pina A et al. OCT Predictors of 3-Year Visual Outcome for Type 3 Macular Neovascularization. Ophthalmol Retina 2022; : 586-94.

Lains I, Pundlik SJ, Nigalye A, Katz R, Luo G, Kim IK, et al. Baseline Predictors Associated With 3-Year Changes in Dark Adaptation in Age-Related Macular Degeneration. Retina. 2021;41:2098–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wickremasinghe SS, Sandhu SS, Busija L, Lim J, Chauhan DS, Guymer RH. Predictors of AMD treatment response. Ophthalmology. 2012;119:2413–2414.e5.

Article  PubMed  Google Scholar 

AI For Diabetic Retinopathy Screening Gets U.S. FDA Approval. https://www.forbes.com/sites/gilpress/2022/11/15/ai-for-diabetic-retinopathy-screening-gets-us-fda-approval/?sh=3cc039467d83 (accessed 11 Nov 2023).

Barthelmes D, Sutter FKP, Gillies MC. Differential optical densities of intraretinal spaces. Invest Ophthalmol Vis Sci. 2008;49:3529–34.

Article  PubMed  Google Scholar 

Ahlers C, Golbaz I, Einwallner E, Dunavölgyi R, Malamos P, Stock G et al. Identification of Optical Density Ratios in Subretinal Fluid as a Clinically Relevant Biomarker in Exudative Macular Disease. https://doi.org/10.1167/iovs.08-2759.

Neudorfer M, Weinberg A, Loewenstein A, Barak A. Differential optical density of subretinal spaces. Invest Ophthalmol Vis Sci. 2012;53:3104–10.

Article  PubMed  Google Scholar 

Zur D, Frenkel S, Leshno A, Iglicki M, Ben-Artzi Cohen N, Khoury A, et al. Subretinal Fluid Optical Density and Spectral-Domain Optical Coherence Tomography Characteristics for the Diagnosis of Circumscribed Choroidal Hemangioma. Ophthalmologica. 2019;241:195–201.

Article  PubMed  Google Scholar 

Leshno A, Barak A, Loewenstein A, Weinberg A, Neudorfer M. Optical density of subretinal fluid in retinal detachment. Invest Ophthalmol Vis Sci. 2015;56:5432–8.

Article  PubMed  Google Scholar 

Leshno A, Vishnevskia-Dai V, Barak A, Zur D, Gabai S, Moroz I, et al. Optical Density Ratio of the Subretinal Fluid in Choroidal Melanoma and Metastasis. Retina. 2019;39:685–91.

Article  PubMed  Google Scholar 

Durmaz Engin C, Kayabasi M, Koksaldi S, Ipek SC, Saatci AO Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study. Photodiagnosis Photodyn Ther. 2023; 42. https://doi.org/10.1016/j.pdpdt.2023.103634.

Melamud A, Stinnett S, Fekrat S Treatment of Neovascular Age-related Macular Degeneration with Intravitreal Bevacizumab: Efficacy of Three Consecutive Monthly Injections. Am J Ophthalmol. 2008. https://doi.org/10.1016/j.ajo.2008.03.014.

Berlin A, Messinger JD, Balaratnasingam C, Mendis R, Ferrara D, Freund KB, et al. Imaging Histology Correlations of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration. Transl Vis Sci Technol 2023; 12. https://doi.org/10.1167/TVST.12.11.13.

Starzycka M. Free fatty acids in the subretinal fluid. Ophthalmologica. 1983;187:29–33.

Article  CAS  PubMed  Google Scholar 

Heath H, Beck TC, Foulds WS. Chemical composition of subretinal fluid. British J Ophthalmol. 1962;46:385–96.

Article  CAS  Google Scholar